These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1064 related items for PubMed ID: 17709918

  • 1. Polymerase-chain-reaction-based detection of fetal rhesus D and Y-chromosome-specific DNA in the whole blood of pregnant women during different trimesters of pregnancy.
    Al-Yatama MK, Mustafa AS, Al-Kandari FM, Khaja N, Zohra K, Monem RA, Abraham S.
    Med Princ Pract; 2007; 16(5):327-32. PubMed ID: 17709918
    [Abstract] [Full Text] [Related]

  • 2. Detection of Y chromosome-specific DNA in the plasma and urine of pregnant women using nested polymerase chain reaction.
    Al-Yatama MK, Mustafa AS, Ali S, Abraham S, Khan Z, Khaja N.
    Prenat Diagn; 2001 May; 21(5):399-402. PubMed ID: 11360283
    [Abstract] [Full Text] [Related]

  • 3. Prenatal diagnosis of fetal RhD status by molecular analysis of maternal plasma.
    Lo YM, Hjelm NM, Fidler C, Sargent IL, Murphy MF, Chamberlain PF, Poon PM, Redman CW, Wainscoat JS.
    N Engl J Med; 1998 Dec 10; 339(24):1734-8. PubMed ID: 9845707
    [Abstract] [Full Text] [Related]

  • 4. Accuracy of fetal gender detection using a conventional nested PCR assay of maternal plasma in daily practice.
    Tungwiwat W, Fucharoen S, Fucharoen G, Ratanasiri T, Sanchaisuriya K.
    Aust N Z J Obstet Gynaecol; 2008 Oct 10; 48(5):501-4. PubMed ID: 19032667
    [Abstract] [Full Text] [Related]

  • 5. RHD genotyping from maternal plasma: guidelines and technical challenges.
    Avent ND.
    Methods Mol Biol; 2008 Oct 10; 444():185-201. PubMed ID: 18425481
    [Abstract] [Full Text] [Related]

  • 6. Noninvasive fetal blood group genotyping of rhesus D, c, E and of K in alloimmunised pregnant women: evaluation of a 7-year clinical experience.
    Scheffer PG, van der Schoot CE, Page-Christiaens GC, de Haas M.
    BJOG; 2011 Oct 10; 118(11):1340-8. PubMed ID: 21668766
    [Abstract] [Full Text] [Related]

  • 7. [Fetal DNA in maternal blood].
    Rijnders RJ, Christiaens GC, de Haas M, van der Schoot CE.
    Ned Tijdschr Geneeskd; 2004 Jan 24; 148(4):170-4. PubMed ID: 14974307
    [Abstract] [Full Text] [Related]

  • 8. Reliable test for prenatal prediction of fetal RhD type using maternal plasma from RhD negative women.
    Clausen FB, Krog GR, Rieneck K, Nielsen LK, Lundquist R, Finning K, Dickmeiss E, Hedegaard M, Dziegiel MH.
    Prenat Diagn; 2005 Nov 24; 25(11):1040-4. PubMed ID: 16231312
    [Abstract] [Full Text] [Related]

  • 9. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible.
    Müller SP, Bartels I, Stein W, Emons G, Gutensohn K, Köhler M, Legler TJ.
    Transfusion; 2008 Nov 24; 48(11):2292-301. PubMed ID: 18694461
    [Abstract] [Full Text] [Related]

  • 10. Prenatal RHD gene determination and dosage analysis by PCR: clinical evaluation.
    Chan FY, Cowley NM, Wolter L, Stone M, Carmody F, Saul A, Hyland CA.
    Prenat Diagn; 2001 Apr 24; 21(4):321-6. PubMed ID: 11288127
    [Abstract] [Full Text] [Related]

  • 11. [Non invasive prenatal genetic diagnosis of fetal RhD and sex through the analysis of free fetal DNA in maternal plasma].
    Sesarini C, Giménez ML, Redal MA, Izbizky G, Aiello H, Argibay P, Otaño L.
    Arch Argent Pediatr; 2009 Oct 24; 107(5):405-9. PubMed ID: 19809760
    [Abstract] [Full Text] [Related]

  • 12. Noninvasive fetal RHD genotyping by maternal plasma with capillary electrophoresis.
    Kimura M, Sato C, Hara M, Ishihara O, Ikebuchi K.
    Transfusion; 2008 Jun 24; 48(6):1156-63. PubMed ID: 18422850
    [Abstract] [Full Text] [Related]

  • 13. Circulating cell-free fetal DNA for the detection of RHD status and sex using reflex fetal identifiers.
    Moise KJ, Boring NH, O'Shaughnessy R, Simpson LL, Wolfe HM, Baxter JK, Polzin W, Eddleman KA, Hassan SS, Skupski D, McLennan G, Paladino T, Oeth P, Bombard A.
    Prenat Diagn; 2013 Jan 24; 33(1):95-101. PubMed ID: 23225162
    [Abstract] [Full Text] [Related]

  • 14. [Antenatal determination of fetal RhD-blood type based on fetal DNA in plasma from the RhD-negative mother--secondary publication].
    Clausen FB, Krog GR, Rieneck K, Nielsen LK, Lundquist R, Finning K, Dickmeiss E, Hedegaard M, Dziegiel MH.
    Ugeskr Laeger; 2006 Jun 26; 168(26-32):2568-70. PubMed ID: 16824414
    [Abstract] [Full Text] [Related]

  • 15. Accuracy of fetal gender determination in maternal plasma at 5 and 6 weeks of pregnancy.
    Martinhago CD, de Oliveira RM, Tomitão Canas Mdo C, Vagnini LD, Alcantara Oliveira JB, Petersen CG, Franco Junior JG.
    Prenat Diagn; 2006 Dec 26; 26(13):1219-23. PubMed ID: 17089442
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A prospective analysis of cell-free fetal DNA concentration in maternal plasma as an indicator for adverse pregnancy outcome.
    Bauer M, Hutterer G, Eder M, Majer S, Leshane E, Johnson KL, Peter I, Bianchi DW, Pertl B.
    Prenat Diagn; 2006 Sep 26; 26(9):831-6. PubMed ID: 16832830
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood--a meta-analysis.
    Geifman-Holtzman O, Grotegut CA, Gaughan JP.
    Am J Obstet Gynecol; 2006 Oct 26; 195(4):1163-73. PubMed ID: 17000250
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 54.